MétaCan
Menu
Back to cohort

Hyperkalemia in the Early Post Renal Transplant Period

2018· article· en· W2883272405 on OpenAlexaffabout
Emily Christie, Julius Okel, Manjula Gowrishankar

Bibliographic record

VenueTransplantation · 2018
Typearticle
Languageen
FieldMedicine
TopicPotassium and Related Disorders
Canadian institutionsUniversity of Alberta
Fundersnot available
KeywordsHyperkalemiaMedicineCalcineurinTransplantationRenal functionInternal medicineDialysisPopulationKidney transplantationRetrospective cohort studyIntensive care medicineMetabolic acidosis

Abstract

fetched live from OpenAlex

Introduction Hyperkalemia is a recognized and potentially life threatening complication post renal transplantation. Aside from delayed graft function, the most frequent culprit identified is pharmacotherapy. Many of the medications routinely used in the post-transplant period alter renal potassium handling or impair potassium movement into cells. These include calcineurin inhibitors, sulfa based antibiotics, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and beta blockers. Episodic hyperkalemia develops in 44 to 73 percent of transplant recipients on calcineurin inhibitors [1] and is associated with patient morbidity as well as increased health care costs. The aim of this chart review is to assess the prevalence of hyperkalemia in our renal transplant program, and identify any predictive factors to design preventative and therapeutic algorithms in this high risk population. Materials and Methods Retrospective cohort identified all adult renal transplant recipients between July 2011 and August 2017 within the University of Alberta Northern Alberta Renal Program who developed hyperkalemia (defined as serum potassium >5.0 mmol/L) within the first 6 months post-transplant. Patients with abnormal allograft function or delayed graft function were excluded (creatinine >200 umol/L). Patient characteristics, diagnoses, medications, laboratory values and outcomes were extracted from the electronic medical record. A descriptive analysis was undertaken. Results and Discussion Of the 505 renal transplant patients transplanted during the study period, 48 developed at least one episode of hyperkalemia. These episodes were not associated with metabolic acidosis. Most patients had a period of persistent values in the hyperkalemic range. The majority of patients were on the combination of tacrolimus and trimethoprim-sulfamethoxazole, and approximately half of the patients were on a total of 3 or more medications that could contribute to abnormal potassium handling. Elevated tacrolimus levels were only present in 10% of hyperkalemic episodes. Conclusions The prevalence of hyperkalemia among renal transplant recipient in our centre was lower than expected based on published data. Our findings suggest that hyperkalemia in the early post-transplant period is largely related to the additive effects of multiple therapeutic medications altering potassium homeostasis, and does not seem associated with shift due to metabolic acidosis or as a direct effect from supratherapeutic tacrolimus levels. Our recommendation is to consider alternative agents for blood pressure management and PJP prophylaxis in those patients where hyperkalemia is a recurrent issue. Further investigation into which other factors may best predict those post renal transplant patients at risk for hyperkalemia is warranted.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.791
Threshold uncertainty score0.234

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.009
GPT teacher head0.246
Teacher spread0.237 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2018
Admission routes2
Has abstractyes

Explore more

Same venueTransplantationSame topicPotassium and Related DisordersFrench-language works237,207